Silence Therapeutics’ (SLN) Buy Rating Reaffirmed at HC Wainwright
HC Wainwright reiterated their buy rating on shares of Silence Therapeutics (NASDAQ:SLN – Free Report) in a report published on Friday,Benzinga reports. The firm currently has a $75.00 price target on the stock. SLN has been the topic of a number of other research reports. Morgan Stanley dropped their price target on Silence Therapeutics from […]
HC Wainwright reiterated their buy rating on shares of Silence Therapeutics (NASDAQ:SLN – Free Report) in a report published on Friday,Benzinga reports. The firm currently has a $75.00 price target on the stock. SLN has been the topic of a number of other research reports. Morgan Stanley dropped their price target on Silence Therapeutics from […]
